Stock Analysts’ Price Target Changes for November 9th (ALB, AMH, APLE, ATMU, CC, CG, DVN, ELAN, EOG, FSLY)

Stock Analysts’ price target changes for Monday, November 9th:

Albemarle (NYSE:ALB) had its price target lowered by UBS Group from $150.00 to $137.00. The firm currently has a buy rating on the stock.

American Homes 4 Rent (NYSE:AMH) had its target price raised by UBS Group from $32.00 to $34.00. The firm currently has a neutral rating on the stock.

Apple Hospitality REIT (NYSE:APLE) had its target price increased by JPMorgan Chase & Co. from $17.00 to $18.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.

Atmus Filtration Technologies (NYSE:ATMU) had its price target boosted by JPMorgan Chase & Co. from $54.00 to $60.00. They currently have an overweight rating on the stock.

Chemours (NYSE:CC) had its target price reduced by JPMorgan Chase & Co. from $15.00 to $14.00. They currently have a neutral rating on the stock.

Carlyle Group (NASDAQ:CG) had its price target reduced by JPMorgan Chase & Co. from $64.00 to $62.00. They currently have a neutral rating on the stock.

Devon Energy (NYSE:DVN) had its target price raised by JPMorgan Chase & Co. from $65.00 to $68.00. The firm currently has an overweight rating on the stock.

Elanco Animal Health (NYSE:ELAN) had its price target increased by JPMorgan Chase & Co. from $33.00 to $35.00. The firm currently has an overweight rating on the stock.

EOG Resources (NYSE:EOG) had its price target raised by UBS Group from $186.00 to $190.00. UBS Group currently has a buy rating on the stock.

Fastly (NASDAQ:FSLY) had its price target cut by Freedom Broker from $37.00 to $35.00. The firm currently has a buy rating on the stock.

Six Flags Entertainment (NYSE:FUN) had its target price cut by JPMorgan Chase & Co. from $22.00 to $12.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.

FrontView REIT (NYSE:FVR) had its target price reduced by Freedom Broker from $22.00 to $21.00. They currently have a buy rating on the stock.

Home Depot (NYSE:HD) had its price target raised by JPMorgan Chase & Co. from $396.00 to $400.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.

Helios Technologies (NYSE:HLIO) had its target price trimmed by JPMorgan Chase & Co. from $110.00 to $90.00. They currently have an overweight rating on the stock.

IREN (NASDAQ:IREN) had its target price reduced by JPMorgan Chase & Co. from $65.00 to $55.00. They currently have an overweight rating on the stock.

Kayne Anderson BDC (NYSE:KBDC) had its target price reduced by UBS Group from $13.50 to $12.50. The firm currently has a neutral rating on the stock.

Kratos Defense & Security Solutions (NASDAQ:KTOS) had its price target lowered by UBS Group from $60.00 to $46.00. The firm currently has a neutral rating on the stock.

Lowe’s Companies (NYSE:LOW) had its target price boosted by JPMorgan Chase & Co. from $252.00 to $275.00. The firm currently has an overweight rating on the stock.

Main Street Capital (NYSE:MAIN) had its price target increased by UBS Group from $57.00 to $58.00. The firm currently has a neutral rating on the stock.

MercadoLibre (NASDAQ:MELI) had its target price cut by JPMorgan Chase & Co. from $2,150.00 to $1,850.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.

Mettler-Toledo International (NYSE:MTD) had its price target boosted by JPMorgan Chase & Co. from $1,550.00 to $1,725.00. The firm currently has a neutral rating on the stock.

Nutrien (NYSE:NTR) had its target price boosted by JPMorgan Chase & Co. from $75.00 to $80.00. They currently have an overweight rating on the stock.

Pacific Biosciences of California (NASDAQ:PACB) had its target price cut by UBS Group from $3.05 to $2.70. The firm currently has a neutral rating on the stock.

Progyny (NASDAQ:PGNY) had its target price increased by JPMorgan Chase & Co. from $30.00 to $35.00. The firm currently has a neutral rating on the stock.

Portillo’s (NASDAQ:PTLO) had its target price raised by UBS Group from $4.50 to $7.00. They currently have a neutral rating on the stock.

TFI International (NYSE:TFII) had its price target lowered by UBS Group from $159.00 to $114.00. The firm currently has a neutral rating on the stock.

Target (NYSE:TGT) had its price target raised by JPMorgan Chase & Co. from $157.00 to $163.00. They currently have a neutral rating on the stock.

TransMedics Group (NASDAQ:TMDX) had its price target increased by UBS Group from $77.00 to $88.00. The firm currently has a neutral rating on the stock.

10x Genomics (NASDAQ:TXG) had its target price cut by JPMorgan Chase & Co. from $70.00 to $65.00. The firm currently has a neutral rating on the stock.

Under Armour (NYSE:UAA) had its price target reduced by Telsey Advisory Group from $5.50 to $5.00. The firm currently has a market perform rating on the stock.

Veracyte (NASDAQ:VCYT) had its target price lowered by UBS Group from $65.00 to $35.00. UBS Group currently has a buy rating on the stock.

Vinci Compass Investments (NASDAQ:VINP) had its price target reduced by UBS Group from $12.00 to $10.50. UBS Group currently has a buy rating on the stock.

Viemed Healthcare (NASDAQ:VMD) had its target price reduced by Freedom Broker from $11.00 to $10.00. They currently have a hold rating on the stock.

Viasat (NASDAQ:VSAT) had its target price reduced by JPMorgan Chase & Co. from $130.00 to $120.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.

Walmart (NASDAQ:WMT) had its price target increased by JPMorgan Chase & Co. from $125.00 to $145.00. They currently have an overweight rating on the stock.

Walmart (NASDAQ:WMT) had its price target raised by UBS Group from $130.00 to $149.00. The firm currently has a buy rating on the stock.